Poseida Therapeutics, Inc.

Report date
12/31/2024
Quarter
2024 Q4
Filed
2/14/2025
Shares
8,625,000
Value ($000)
82,800
Weight
1.4%
2020 Q3 - 2024 Q4 (18 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).